LV Pharma Holding SRL
LV Pharma Holding reported total assets of €2.44m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
By total assets for 2025, LV Pharma Holding ranks among the 10,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of LV Pharma Holding shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LV Pharma Holding's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 28 Jul 2025
LV Pharma Holding's financial analysis
- Solvency18.5%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LV Pharma Holding
LV Pharma Holding's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1013.988.411
- VAT number
- BE1013988411
- Peppol
- Registered · 0208:1013988411 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Sep 2024
- Registered office
- 4430 Ans
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
LV Pharma Holding (SRL) has been based in Ans since 2024, active in: activities of holding companies. For 2025, it reports a net profit of 368,607 € and equity of 450,315 €; its revenue is not published. Its solvency stands at 18.5%, below the median of its sector (46.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to LV Pharma Holding
Companies in the same business, of comparable size and area, outside its group.
- Curafin Activities of holding companies Kortrijk · balance sheet €2.43m
- VMC Holding Activities of holding companies Dilbeek · balance sheet €2.43m
- BaCoBo Activities of holding companies Lier · balance sheet €2.43m
- Allfac-Immo Activities of holding companies Merelbeke-Melle · balance sheet €2.44m
- Sochriman Activities of holding companies Torhout · balance sheet €2.44m
- Thomas Seynaeve Activities of holding companies Beernem · balance sheet €2.43m
- META Activities of holding companies Sint-Martens-Latem · balance sheet €2.43m
- TAS en PC COMPANY Activities of holding companies Zele · balance sheet €2.44m
Frequently asked questions about LV Pharma Holding
What is the revenue of LV Pharma Holding?
LV Pharma Holding files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LV Pharma Holding?
In Belgium, the VAT number is the company number prefixed with BE: BE1013988411 for LV Pharma Holding, if the company is VAT-registered. Its company number (CBE) is 1013.988.411.
Where is the registered office of LV Pharma Holding?
According to the CBE register, the registered office of LV Pharma Holding is in 4430 Ans.
What is the equity of LV Pharma Holding?
At the close of the 2025 financial year, the equity of LV Pharma Holding amounts to 450,315 €, a solvency of 18.5% of total assets.
Who manages LV Pharma Holding?
The register lists 1 active mandates at LV Pharma Holding. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is LV Pharma Holding within its sector?
By total assets for 2025, LV Pharma Holding ranks among the 10,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year.
The full file of LV Pharma Holding
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →